Migdal Insurance & Financial Holdings Ltd. decreased its position in shares of HealthSouth Corporation (NYSE:HLS) by 56.9% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,164 shares of the company’s stock after selling 4,173 shares during the period. Migdal Insurance & Financial Holdings Ltd.’s holdings in HealthSouth Corporation were worth $154,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. First Mercantile Trust Co. raised its position in shares of HealthSouth Corporation by 18.8% during the second quarter. First Mercantile Trust Co. now owns 2,720 shares of the company’s stock valued at $132,000 after buying an additional 430 shares during the last quarter. Acrospire Investment Management LLC raised its position in shares of HealthSouth Corporation by 64.7% during the second quarter. Acrospire Investment Management LLC now owns 2,800 shares of the company’s stock valued at $136,000 after buying an additional 1,100 shares during the last quarter. Advisor Group Inc. raised its position in shares of HealthSouth Corporation by 33.8% during the second quarter. Advisor Group Inc. now owns 3,092 shares of the company’s stock valued at $149,000 after buying an additional 781 shares during the last quarter. Petrus Trust Company LTA bought a new stake in shares of HealthSouth Corporation during the second quarter valued at approximately $210,000. Finally, HL Financial Services LLC bought a new stake in shares of HealthSouth Corporation during the second quarter valued at approximately $213,000. Institutional investors own 93.05% of the company’s stock.
HealthSouth Corporation (NYSE HLS) traded down 0.755% on Thursday, hitting $45.365. 54,345 shares of the company were exchanged. HealthSouth Corporation has a 52-week low of $36.97 and a 52-week high of $49.71. The stock has a market capitalization of $4.48 billion, a P/E ratio of 16.532 and a beta of 0.58. The stock’s 50-day moving average price is $45.09 and its 200-day moving average price is $45.33.
HealthSouth Corporation (NYSE:HLS) last announced its earnings results on Monday, July 31st. The company reported $0.71 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.68 by $0.03. The business had revenue of $981.30 million during the quarter, compared to the consensus estimate of $976.46 million. HealthSouth Corporation had a return on equity of 25.07% and a net margin of 6.70%. The business’s quarterly revenue was up 6.6% on a year-over-year basis. During the same period in the prior year, the company posted $0.69 EPS. On average, equities research analysts anticipate that HealthSouth Corporation will post $2.71 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Investors of record on Monday, October 2nd will be paid a $0.25 dividend. This is an increase from HealthSouth Corporation’s previous quarterly dividend of $0.24. This represents a $1.00 annualized dividend and a yield of 2.19%. The ex-dividend date of this dividend is Friday, September 29th. HealthSouth Corporation’s dividend payout ratio is currently 36.76%.
HLS has been the topic of several recent analyst reports. KeyCorp initiated coverage on shares of HealthSouth Corporation in a research report on Thursday, June 15th. They set a “sector weight” rating on the stock. ValuEngine cut shares of HealthSouth Corporation from a “buy” rating to a “hold” rating in a research report on Friday, September 1st. Zacks Investment Research cut shares of HealthSouth Corporation from a “buy” rating to a “hold” rating in a research report on Tuesday, August 15th. BidaskClub upgraded shares of HealthSouth Corporation from a “sell” rating to a “hold” rating in a research report on Saturday, June 17th. Finally, Royal Bank Of Canada reiterated a “buy” rating and set a $53.00 price objective on shares of HealthSouth Corporation in a research report on Wednesday, July 5th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and four have given a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $50.38.
In related news, CEO Mark J. Tarr sold 22,625 shares of the stock in a transaction on Monday, August 7th. The stock was sold at an average price of $43.00, for a total value of $972,875.00. Following the completion of the transaction, the chief executive officer now directly owns 283,134 shares of the company’s stock, valued at approximately $12,174,762. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.60% of the stock is currently owned by corporate insiders.
COPYRIGHT VIOLATION WARNING: “HealthSouth Corporation (HLS) Holdings Reduced by Migdal Insurance & Financial Holdings Ltd.” was first posted by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this story on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright law. The legal version of this story can be read at https://sportsperspectives.com/2017/10/12/healthsouth-corporation-hls-holdings-reduced-by-migdal-insurance-financial-holdings-ltd.html.
About HealthSouth Corporation
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with MarketBeat.com's FREE daily email newsletter.